Insulin and Insulin-like Growth Factor I Regulate a Thyroid-specific Nuclear Protein That Binds to the Thyroglobulin Promoter
Overview
Molecular Biology
Authors
Affiliations
The mechanism responsible for the stimulation of thyroglobulin (Tg) gene expression by insulin and insulin-like growth factor I (IGF-I) in rat thyroid FRTL-5 cells has been investigated. Both insulin and IGF-I stimulate transcription from the Tg promoter in a transient transfection assay demonstrating that the promoter used contains the DNA signals necessary for insulin and IGF-I regulation. Promoter mutations that interfere with the binding of thyroid transcription factor 1 (TTF-1), TTF-2, and the ubiquitous transcription factor abolish the insulin/IGF-I response, indicating that the three factors may be involved in the observed transcriptional control. Protein-DNA binding studies did not reveal any effect of insulin/IGF-I on the ubiquitous transcription factor and the TTF-1 binding capacity. Instead, TTF-2 is absent in nuclear extracts from cells depleted of serum and insulin. Addition of insulin or IGF-I restores the TTF-2 concentration to normal levels and requires ongoing protein synthesis. The insulin effect was maximal at 24 h and at a concentration of 1 microgram/ml. The same effect was observed with a 10-fold lower concentration of IGF-I. These results suggest that insulin (probably through the IGF-I receptor) and IGF-I modulate the levels of TTF-2, which results in an increased expression of the Tg gene.
Perfluorooctanesulfonic acid (PFOS) disrupts cadherin-16 in the developing rat thyroid gland.
Davidsen N, Ramhoj L, Ballegaard A, Rosenmai A, Henriksen C, Svingen T Curr Res Toxicol. 2024; 6:100154.
PMID: 38352163 PMC: 10861841. DOI: 10.1016/j.crtox.2024.100154.
Lim G, Widiapradja A, Levick S, McKelvey K, Liao X, Refetoff S Endocrinology. 2022; 163(12).
PMID: 36156081 PMC: 9618408. DOI: 10.1210/endocr/bqac158.
Liu Y, Gong J, Huang Y, Xing S, Chen L, Yi T J Cancer. 2022; 13(8):2673-2682.
PMID: 35711846 PMC: 9174864. DOI: 10.7150/jca.71514.
Topaloglu O, Evren B, Uzun M, Yologlu S, Guldogan E, Sahin I Acta Endocrinol (Buchar). 2021; 17(1):138-146.
PMID: 34539923 PMC: 8417482. DOI: 10.4183/aeb.2021.138.
Lopez-Marquez A, Carrasco-Lopez C, Fernandez-Mendez C, Santisteban P Front Endocrinol (Lausanne). 2021; 12:654569.
PMID: 33959098 PMC: 8095082. DOI: 10.3389/fendo.2021.654569.